Format
Sort by
Items per page

Send to

Choose Destination

Best matches for epistasis multiple sclerosis:

Human Epistatic Interaction Controls IL7R Splicing and Increases Multiple Sclerosis Risk. Galarza-Muñoz G et al. Cell. (2017)

Class II HLA interactions modulate genetic risk for multiple sclerosis. Moutsianas L et al. Nat Genet. (2015)

Multiple sclerosis genetics is dead. Hawkes CH et al. Mult Scler Relat Disord. (2013)

Search results

Items: 1 to 20 of 58

1.

Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk.

International Multiple Sclerosis Genetics Consortium. Electronic address: chris.cotsapas@yale.edu; International Multiple Sclerosis Genetics Consortium.

Cell. 2018 Nov 29;175(6):1679-1687.e7. doi: 10.1016/j.cell.2018.09.049. Epub 2018 Oct 18.

2.

Pharmacogenetics of glatiramer acetate therapy for multiple sclerosis: the impact of genome-wide association studies identified disease risk loci.

Kulakova O, Bashinskaya V, Kiselev I, Baulina N, Tsareva E, Nikolaev R, Kozin M, Shchur S, Favorov A, Boyko A, Favorova O.

Pharmacogenomics. 2017 Nov;18(17):1563-1574. doi: 10.2217/pgs-2017-0058. Epub 2017 Nov 2.

PMID:
29095108
3.

Combination of Myelin Basic Protein Gene Polymorphisms with HLA-DRB1*1501 in Iranian Patients with Multiple Sclerosis.

Nejati P, Attar M, Rahimian M, Fathi D, Shahbazi M.

Iran J Immunol. 2017 Sep;14(3):231-239. doi: IJIv14i3A6.

4.

Human Epistatic Interaction Controls IL7R Splicing and Increases Multiple Sclerosis Risk.

Galarza-Muñoz G, Briggs FBS, Evsyukova I, Schott-Lerner G, Kennedy EM, Nyanhete T, Wang L, Bergamaschi L, Widen SG, Tomaras GD, Ko DC, Bradrick SS, Barcellos LF, Gregory SG, Garcia-Blanco MA.

Cell. 2017 Mar 23;169(1):72-84.e13. doi: 10.1016/j.cell.2017.03.007.

5.

Functional Promoter Polymorphisms of MMP-2 C-735T and MMP-9 C-1562T and Their Synergism with MMP-7 A-181G in Multiple Sclerosis.

Rahimi Z, Abdan Z, Rahimi Z, Razazian N, Shiri H, Vaisi-Raygani A, Shakiba E, Vessal M, Moradi MT.

Immunol Invest. 2016 Aug;45(6):543-52. doi: 10.1080/08820139.2016.1180303. Epub 2016 Jul 13.

PMID:
27409770
6.

Network Modeling of Crohn's Disease Incidence.

Victor JM, Debret G, Lesne A, Pascoe L, Carrivain P, Wainrib G, Hugot JP.

PLoS One. 2016 Jun 16;11(6):e0156138. doi: 10.1371/journal.pone.0156138. eCollection 2016.

7.

Class II HLA interactions modulate genetic risk for multiple sclerosis.

Moutsianas L, Jostins L, Beecham AH, Dilthey AT, Xifara DK, Ban M, Shah TS, Patsopoulos NA, Alfredsson L, Anderson CA, Attfield KE, Baranzini SE, Barrett J, Binder TMC, Booth D, Buck D, Celius EG, Cotsapas C, D'Alfonso S, Dendrou CA, Donnelly P, Dubois B, Fontaine B, Fugger L, Goris A, Gourraud PA, Graetz C, Hemmer B, Hillert J; International IBD Genetics Consortium (IIBDGC), Kockum I, Leslie S, Lill CM, Martinelli-Boneschi F, Oksenberg JR, Olsson T, Oturai A, Saarela J, Søndergaard HB, Spurkland A, Taylor B, Winkelmann J, Zipp F, Haines JL, Pericak-Vance MA, Spencer CCA, Stewart G, Hafler DA, Ivinson AJ, Harbo HF, Hauser SL, De Jager PL, Compston A, McCauley JL, Sawcer S, McVean G.

Nat Genet. 2015 Oct;47(10):1107-1113. doi: 10.1038/ng.3395. Epub 2015 Sep 7.

8.

Influence of the LILRA3 Deletion on Multiple Sclerosis Risk: Original Data and Meta-Analysis.

Ortiz MA, Núñez C, Ordóñez D, Alvarez-Cermeño JC, Martínez-Rodriguez JE, Sánchez AJ, Arroyo R, Izquierdo G, Malhotra S, Montalban X, García-Merino A, Munteis E, Alcina A, Comabella M, Matesanz F, Villar LM, Urcelay E.

PLoS One. 2015 Aug 14;10(8):e0134414. doi: 10.1371/journal.pone.0134414. eCollection 2015.

9.

Genetics and novel aspects of therapies in systemic lupus erythematosus.

Relle M, Weinmann-Menke J, Scorletti E, Cavagna L, Schwarting A.

Autoimmun Rev. 2015 Nov;14(11):1005-18. doi: 10.1016/j.autrev.2015.07.003. Epub 2015 Jul 9. Review.

PMID:
26164648
10.

Genome-Wide Analysis of Gene-Gene and Gene-Environment Interactions Using Closed-Form Wald Tests.

Yu Z, Demetriou M, Gillen DL.

Genet Epidemiol. 2015 Sep;39(6):446-55. doi: 10.1002/gepi.21907. Epub 2015 Jun 10.

11.

Role of a Novel Human Leukocyte Antigen-DQA1*01:02;DRB1*15:01 Mixed Isotype Heterodimer in the Pathogenesis of "Humanized" Multiple Sclerosis-like Disease.

Kaushansky N, Eisenstein M, Boura-Halfon S, Hansen BE, Nielsen CH, Milo R, Zeilig G, Lassmann H, Altmann DM, Ben-Nun A.

J Biol Chem. 2015 Jun 12;290(24):15260-78. doi: 10.1074/jbc.M115.641209. Epub 2015 Apr 24.

12.

Genetic analysis of an allergic rhinitis cohort reveals an intercellular epistasis between FAM134B and CD39.

Melchiotti R, Puan KJ, Andiappan AK, Poh TY, Starke M, Zhuang L, Petsch K, Lai TS, Chew FT, Larbi A, Wang de Y, Poidinger M, Rotzschke O.

BMC Med Genet. 2014 Jun 27;15:73. doi: 10.1186/1471-2350-15-73.

13.

Family studies of type 1 diabetes reveal additive and epistatic effects between MGAT1 and three other polymorphisms.

Yu Z, Li CF, Mkhikian H, Zhou RW, Newton BL, Demetriou M.

Genes Immun. 2014 Apr;15(4):218-23. doi: 10.1038/gene.2014.7. Epub 2014 Feb 27.

14.

Variability in the CIITA gene interacts with HLA in multiple sclerosis.

Gyllenberg A, Piehl F, Alfredsson L, Hillert J, Bomfim IL, Padyukov L, Orho-Melander M, Lindholm E, Landin-Olsson M, Lernmark Å; Swedish Childhood Diabetes Study Group; Diabetes Incidence in Sweden Study Group, Olsson T, Kockum I.

Genes Immun. 2014 Apr-May;15(3):162-7. doi: 10.1038/gene.2013.71. Epub 2014 Jan 16.

PMID:
24430172
15.

DNase hypersensitive sites and association with multiple sclerosis.

Disanto G, Kjetil Sandve G, Ricigliano VA, Pakpoor J, Berlanga-Taylor AJ, Handel AE, Kuhle J, Holden L, Watson CT, Giovannoni G, Handunnetthi L, Ramagopalan SV.

Hum Mol Genet. 2014 Feb 15;23(4):942-8. doi: 10.1093/hmg/ddt489. Epub 2013 Oct 2.

PMID:
24092328
16.

Combining genetic mapping with genome-wide expression in experimental autoimmune encephalomyelitis highlights a gene network enriched for T cell functions and candidate genes regulating autoimmunity.

Thessen Hedreul M, Möller S, Stridh P, Gupta Y, Gillett A, Daniel Beyeen A, Öckinger J, Flytzani S, Diez M, Olsson T, Jagodic M.

Hum Mol Genet. 2013 Dec 15;22(24):4952-66. doi: 10.1093/hmg/ddt343. Epub 2013 Jul 29.

17.

Vitamin D3 receptor ( VDR ) gene rs2228570 (Fok1) and rs731236 (Taq1) variants are not associated with the risk for multiple sclerosis: results of a new study and a meta-analysis.

García-Martín E, Agúndez JA, Martínez C, Benito-León J, Millán-Pascual J, Calleja P, Díaz-Sánchez M, Pisa D, Turpín-Fenoll L, Alonso-Navarro H, Ayuso-Peralta L, Torrecillas D, Plaza-Nieto JF, Jiménez-Jiménez FJ.

PLoS One. 2013 Jun 20;8(6):e65487. doi: 10.1371/journal.pone.0065487. Print 2013.

18.

Multiple sclerosis genetics is dead.

Hawkes CH.

Mult Scler Relat Disord. 2013 Jul;2(3):156-61. doi: 10.1016/j.msard.2012.12.006. Epub 2013 Feb 16. Review.

PMID:
25877721
19.

Network-based multiple sclerosis pathway analysis with GWAS data from 15,000 cases and 30,000 controls.

International Multiple Sclerosis Genetics Consortium.

Am J Hum Genet. 2013 Jun 6;92(6):854-65. doi: 10.1016/j.ajhg.2013.04.019. Epub 2013 May 23.

20.

Disease-association analysis of an inflammation-related feedback loop.

Murakami M, Harada M, Kamimura D, Ogura H, Okuyama Y, Kumai N, Okuyama A, Singh R, Jiang JJ, Atsumi T, Shiraya S, Nakatsuji Y, Kinoshita M, Kohsaka H, Nishida M, Sakoda S, Miyasaka N, Yamauchi-Takihara K, Hirano T.

Cell Rep. 2013 Mar 28;3(3):946-59. doi: 10.1016/j.celrep.2013.01.028. Epub 2013 Feb 21. Erratum in: Cell Rep. 2013 May 30;3(5):1754. Yamaguchi-Takihara, Keiko [corrected to Yamauchi-Takihara, Keiko].

Supplemental Content

Loading ...
Support Center